Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04979013 · ClinicalTrials.gov registry record · NA

BRP1802 Smoking Abstinence Study

A NA study, sponsored by RAI Services Company.

Completed
Registry status
NA
Development phase
70
Enrollment target

NCT04979013 is a NA study that has completed, run by RAI Services Company. The registered enrollment target is 70 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04979013, a NA study, has completed, sponsored by RAI Services Company.

COMPLETED
Registry status
NA
Development phase
70 participants
Enrollment target

Study Summary

A single-center study designed to evaluate changes in short-term biomarkers of potential harm (BoPH) in healthy adult cigarette smokers of two age groups (Group A: 24-34 years; Group B: 35-60 years) during 14 days of smoking abstinence.

Interventions

  • OTHER Smoking Abstinence

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2019-05-30
Est. Completion 2019-12-05
Phase NA

Sponsor

RAI Services Company

42 total trials

What the Registry Record Tells You About NCT04979013

The ClinicalTrials.gov registry entry for NCT04979013 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RAI Services Company, which has 42 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Smoking Abstinence is the first listed.

NCT04979013 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04979013 about?

NCT04979013 is a clinical study titled "BRP1802 Smoking Abstinence Study". A single-center study designed to evaluate changes in short-term biomarkers of potential harm (BoPH) in healthy adult cigarette smokers of two age groups (Group A: 24-34 years; Group B: 35-60 years) during 14 days of smoking abstinence.

What is the current status of trial NCT04979013?

This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2019-05-30. Estimated completion is 2019-12-05.

What interventions are being tested in trial NCT04979013?

The interventions under investigation include: Smoking Abstinence (OTHER).

Who is sponsoring clinical trial NCT04979013?

This trial is sponsored by RAI Services Company, which has 42 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.